ANSATIPINE Side Effects

6674716-0 | Leukopenia, Neutropenia, Rhabdomyolysis
on Mar 29, 2010 Male patient from FRANCE , 41 years of age, was diagnosed with mycobacterium avium complex infection, hiv infection (What is hiv infection?), prophylaxis and was treated with Ansatipine (View Usage). Patient experienced the following unwanted or unexpected effects: leukopenia, neutropenia, rhabdomyolysis. Ansatipine dosage: 300 Mg Per Day. During the same period patient was treated with ZECLAR (500 Mg, Alternate Day) (View Zeclar Review and Zeclar Label ), FUZEON (Unk) (View Fuzeon Review and Fuzeon Label ), ABACAVIR/LAMIVUDINE (Unk) (View Abacavir/lamivudine Review and Abacavir/lamivudine Label ), ISENTRESS (Unk) (View Isentress Review and Isentress Label ), BACTRIM (Unk) (View Bactrim Review and Bactrim Label ), DOMPERIDONE (Unk) (View Domperidone Review and Domperidone Label ), IMOVANE (Unk) (View Imovane Review and Imovane Label ), CRESTOR (Unk) (View Crestor Review and Crestor Label ). Patient was hospitalized.

6349100-X | Erythema, Hypersensitivity, Hypotension, Livedo Reticularis, Pyrexia, Transaminases Increased
Patient was taking Ansatipine (View Usage). Patient had the following side effects: erythema, hypersensitivity, hypotension, livedo reticularis, pyrexia, transaminases increased on Aug 31, 2009 from FRANCE Additional patient health information: Female patient , 55 years of age, was diagnosed with lymph node tuberculosis and. Ansatipine dosage: 450 Mg, Unk. During the same period patient was treated with MYAMBUTOL (1200 Mg, Unk) (View Myambutol Review and Myambutol Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), ETHAMBUTOL (View Ethambutol Review and Ethambutol Label ). Patient was hospitalized.

5974985-6 | Arthralgia, Eosinophilia, Rash Maculo-papular, Vomiting
Adverse event was reported on Nov 20, 2008 by a Female patient taking Ansatipine (View Usage) (Dosage: ) . Location: FRANCE , weighting 132.3 lb, After Ansatipine was administered, patient had the following side effects: arthralgia, eosinophilia, rash maculo-papular, vomiting. During the same period patient was treated with RIMIFON (View Rimifon Review and Rimifon Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), MYAMBUTOL (View Myambutol Review and Myambutol Label ), MOXIFLOXACIN HYDROCHLORIDE (View Moxifloxacin Hydrochloride Review and Moxifloxacin Hydrochloride Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), CALCIUM CARBONATE/COLECALCIFEROL (View Calcium Carbonate/colecalciferol Review and Calcium Carbonate/colecalciferol Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

5844096-9 | Arthralgia, Synovitis
on Aug 01, 2008 Male patient from FRANCE , weighting 160.9 lb, was diagnosed with pulmonary tuberculosis, hiv infection (What is hiv infection?) and was treated with Ansatipine (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, synovitis. Ansatipine dosage: . During the same period patient was treated with KALETRA (View Kaletra Review and Kaletra Label ), IZILOX (View Izilox Review and Izilox Label ), VIREAD (View Viread Review and Viread Label ), COMBIVIR (View Combivir Review and Combivir Label ). Patient was hospitalized.


5741012-5 | Cholestasis, Neutropenia
on May 05, 2008 Male patient from FRANCE , 38 years of age, was treated with Ansatipine (View Usage). Patient had the following side effects: cholestasis, neutropenia. Ansatipine dosage: . During the same period patient was treated with ISONIAZID (Text:2 Df-freq:interval: Every Day) (View Isoniazid Review and Isoniazid Label ), KALETRA (Text:4 Df) (View Kaletra Review and Kaletra Label ), TRUVADA (View Truvada Review and Truvada Label ), MYAMBUTOL (View Myambutol Review and Myambutol Label ), PIRILENE (View Pirilene Review and Pirilene Label ), BACTRIM (View Bactrim Review and Bactrim Label ).

5273166-1 | Alanine Aminotransferase Increased
Patient was taking Ansatipine (View Usage). After Ansatipine was administered, patient had the following side effects: alanine aminotransferase increased on Mar 12, 2007 from FRANCE Additional patient health information: Male patient , 44 years of age, . Ansatipine dosage: . During the same period patient was treated with ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ). Patient was hospitalized.

5273044-8 | Optic Neuritis
Adverse event was reported on Mar 13, 2007 by a Male patient taking Ansatipine (View Usage) (Dosage: Text:2 Doses Form) was diagnosed with pulmonary tuberculosis and. Location: FRANCE , 58 years of age, Patient experienced the following unwanted or unexpected effects: optic neuritis. During the same period patient was treated with ZECLAR (Text:3 Doses Form) (View Zeclar Review and Zeclar Label ), ETHAMBUTOL DIHYDROCHLORIDE (Text:2.5 Dose Form) (View Ethambutol Dihydrochloride Review and Ethambutol Dihydrochloride Label ). Patient was hospitalized.